,FDA,Breakthrough,S6MhoDINYok,, Health,Knowledge, channel_UCVss7X5VoHk7kmfrBkpnYKQ, video_S6MhoDINYok,The FDA has several programs aimed at streamlining and accelerating the development and review of new drugs for the treatment of serious or life-threatening conditions, particularly where there is an unmet medical need
The programs include: breakthrough therapy designation, fast track designation, accelerated approval, and priority review and we provide a quick overview about the same.
For more details:
https://www.fda.gov/regulatory-information/food-and-drug-administration-safety-and-innovation-act-fdasia/frequently-asked-questions-breakthrough-therapies
